Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles M. Baum currently holds 20,275 shares of Mirati Therapeutics, Inc. (MRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles M. Baum has been a net seller of MRTX stock. They have purchased $225.8K and sold $49.3M worth of shares.
Charles M. Baum's most recent insider trade was on Jun 20, 2024, when they sold 20,275 shares at $0.00 per share.
Charles M. Baum serves as Executive at Mirati Therapeutics, Inc. (MRTX). They have executed 117 insider transactions totaling $49.5M over their tenure at the company.
Charles M. Baum holds the position of Executive at Mirati Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Charles M. Baum has shown a selling trading pattern, with $225.8K in total purchases and $49.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Charles M. Baum was on Nov 28, 2022, when they sold $6.9M worth of MRTX shares. This transaction involved 69,256 shares at $100.00 per share.
Charles M. Baum currently owns 20,275 shares of Mirati Therapeutics, Inc. (MRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles M. Baum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles M. Baum has 117 Form 4 filings on record as an insider at Mirati Therapeutics, Inc..
Set alerts for Charles M. Baum and 40,000+ other insiders.